Effects of Adapted Argentine Tango Training Frequency on Dual-Task Walking (AAT-FREQ)

August 28, 2026 updated by: Xiaodong Cheng, Xi'an Medical University

Effects of Adapted Argentine Tango Training Frequency Under Equal Weekly Exercise Volume on Dual-Task Walking and Executive Function in Adults Aged 55 to 60 Years: A Three-Arm Parallel Randomized Controlled Trial

This randomized controlled trial will examine whether the frequency of adapted Argentine tango training affects walking and cognitive function in adults aged 55 to 60 years when the total weekly intervention time is kept the same.

A total of 270 participants will be randomly assigned in equal numbers to one of three groups. The distributed tango group will attend five 36-minute sessions per week. The concentrated tango group will attend two 90-minute sessions per week. The active control group will attend two 90-minute sessions per week consisting of health education and low-intensity stretching. All interventions will continue for 8 weeks.

The adapted Argentine tango program will include low-impact multidirectional stepping, weight shifting, movement initiation and stopping, rhythmic cueing, direction changes, alternating leader-follower roles, and progressive movement-sequence learning. Jumping, rapid continuous turning, large kicks, and other high-risk movements will not be included.

Assessments will be conducted at baseline, Week 4, Week 8, and 2 weeks after the intervention ends. The main outcome will be the change in dual-task walking cost at week 8. Other assessments will examine balance, walking performance, executive function, general cognitive function, lower-limb function, exercise adherence, training intensity, falls, and adverse events.

The study aims to determine whether shorter, more frequent sessions or longer, less frequent sessions provide greater motor-cognitive benefits when the total weekly intervention time is equal.

Study Overview

Detailed Description

Dance combines aerobic activity, dynamic balance, rhythmic movement, motor-sequence learning, spatial orientation, and cognitive-motor coordination. Adapted Argentine tango may be particularly suitable for improving motor-cognitive function because it requires multidirectional stepping, weight shifting, movement initiation and cessation, direction changes, rhythmic synchronization, and continuous planning of subsequent movements.

Previous dance intervention studies have varied substantially in dance style, training frequency, session duration, exercise intensity, and total training volume. Consequently, it remains unclear whether the distribution of training sessions across the week independently influences motor-cognitive outcomes. This study will compare two adapted Argentine tango schedules while maintaining the same total weekly intervention time.

This will be a single-center, three-arm, parallel randomized controlled trial involving 270 adults aged 55 to 60 years. After eligibility screening, written informed consent, and baseline assessment, participants will be randomly allocated in a 1:1:1 ratio to a distributed tango group, a concentrated tango group, or an active control group. Randomization will be stratified by sex and implemented using variable block sizes. Outcome assessors and statistical analysts will be blinded to group allocation whenever feasible.

Participants in the distributed tango group will complete five 36-minute sessions per week, providing a total weekly intervention time of 180 minutes. Each session will consist of approximately 6 minutes of warm-up, 24 minutes of adapted tango, and 6 minutes of cool-down. Participants in the concentrated tango group will complete two 90-minute sessions per week, also providing 180 minutes per week. Each session will consist of approximately 15 minutes of warm-up, 60 minutes of adapted tango, and 15 minutes of cool-down, with appropriate rest and water breaks. Participants in the active control group will complete two 90-minute sessions per week consisting of general health education, low-intensity joint mobility exercises, stretching, and relaxation activities. The control program will not include systematic tango steps, progressive movement-sequence learning, or cognitively demanding direction-switching tasks.

The adapted Argentine tango intervention will be progressively delivered over 8 weeks. Early sessions will emphasize postural control, weight shifting, forward stepping, and lateral stepping. Subsequent sessions will introduce backward stepping, movement initiation and stopping, rhythm changes, small crossover steps, and controlled 90-degree turns. Later sessions will incorporate alternating leader-follower roles, music- and direction-based cues, progressively longer movement sequences, and low-difficulty dual-task activities. High-risk movements, including jumping, rapid continuous spinning, deep lunges, large kicks, boleos, ganchos, and eyes-closed movement, will be excluded.

Tango exercise intensity will be targeted at approximately 50% to 65% of heart rate reserve, with a rating of perceived exertion of 11 to 13. Attendance, actual exercise duration, average and peak heart rate, session rating of perceived exertion, interruptions, discomfort, falls, and other adverse events will be recorded throughout the intervention.

Study assessments will be conducted at baseline, week 4, week 8, and 2 weeks after completion of the intervention. Week 8 will be the primary endpoint. No study-provided training will be delivered during the 2-week follow-up period. Physical activity and participation in other exercise programs during follow-up will be documented.

The primary outcome will be the between-group difference in the change from baseline to week 8 in dual-task walking cost. Dual-task walking cost will be calculated from walking speed under single-task and dual-task conditions. Secondary assessments will evaluate dynamic balance, complex mobility, walking performance, executive function, general cognitive function, lower-limb functional performance, walking endurance, intervention adherence, exercise intensity, falls, withdrawals, and adverse events.

The primary analysis will follow the intention-to-treat principle. Longitudinal outcomes will be analyzed using mixed-effects models including group, time, and group-by-time interaction effects. Effect estimates will be reported with 95% confidence intervals. Appropriate adjustment for multiple comparisons and sensitivity analyses for missing data will be conducted according to a prespecified statistical analysis plan.

Study Type

Interventional

Enrollment (Estimated)

270

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Aged 55 to 60 years at the time of enrollment. Able to stand and walk independently without physical assistance from another person.

Able to understand the study procedures and complete the walking, balance, physical function, and cognitive assessments.

No regular dance training during the previous 6 months. Willing to maintain usual daily activities and avoid beginning another structured dance or balance-training program during the study.

Cleared for moderate-intensity exercise based on the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) or an equivalent exercise safety screening. Medical clearance will be required when indicated.

Willing and able to attend the assigned intervention sessions and complete the scheduled assessments.

Able to provide written informed consent.

Exclusion Criteria:

Uncontrolled hypertension, unstable angina, recent myocardial infarction or stroke, severe cardiac arrhythmia, or another cardiovascular condition that makes moderate-intensity exercise unsafe.

A neurological disorder that substantially affects gait, balance, cognition, or the ability to complete the study procedures.

Severe cognitive impairment, psychiatric illness, or communication difficulty that prevents understanding of the study or valid completion of the assessments.

A recent fracture, severe musculoskeletal disorder, acute joint injury, severe dizziness, or another condition associated with an unacceptably high risk of falling or exercise-related injury.

Current participation in another structured dance, balance, cognitive-motor, or exercise intervention study that may affect the study outcomes.

Any other medical or functional condition that, in the judgment of the study investigator or qualified safety assessor, makes participation unsafe or may interfere with completion of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Distributed Adapted Argentine Tango
Participants will complete adapted Argentine tango training five times per week for 8 weeks. Each 36-minute session will include approximately 6 minutes of warm-up, 24 minutes of adapted tango, and 6 minutes of cool-down, providing a total intervention time of 180 minutes per week.
Participants will complete five 36-minute sessions per week for 8 weeks. Training will include low-impact multidirectional stepping, weight shifting, forward and backward stepping, lateral stepping, movement initiation and stopping, rhythm changes, controlled 90-degree turns, alternating leader-follower roles, and progressive motor-sequence learning. The target intensity will be approximately 50% to 65% of heart rate reserve, with a rating of perceived exertion of 11 to 13. Jumping, rapid continuous turning, large kicks, deep lunges, boleos, ganchos, and eyes-closed movements will be excluded.
Other Names:
  • Distributed Adapted Argentine Tango
Experimental: Concentrated Adapted Argentine Tango
Participants will complete adapted Argentine tango training twice per week for 8 weeks. Each 90-minute session will include approximately 15 minutes of warm-up, 60 minutes of adapted tango, and 15 minutes of cool-down, with appropriate rest and water breaks, providing a total intervention time of 180 minutes per week.
Participants will complete two 90-minute sessions per week for 8 weeks. The adapted tango content, progression, weekly intervention time, and target exercise intensity will be matched to the distributed tango group. Each session will include warm-up, 60 minutes of core adapted tango training, cool-down, and appropriate rest and water breaks. High-risk movements will be excluded.
Other Names:
  • Concentrated Adapted Argentine Tango
Experimental: Active Control
Participants will attend two 90-minute sessions per week for 8 weeks. Sessions will consist of general health education, low-intensity joint mobility exercises, stretching, breathing exercises, and relaxation activities. The program will not include systematic tango steps, progressive movement-sequence learning, or cognitively demanding direction-switching tasks.
Participants will complete two 90-minute sessions per week for 8 weeks. The program will include general health education, low-intensity joint mobility exercises, stretching, breathing exercises, and relaxation. It will not include systematic dance training, progressive tango sequences, multidirectional stepping practice, or cognitively demanding movement-switching tasks.
Other Names:
  • Active Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Dual-Task Walking Cost at Week 8
Time Frame: Baseline and Week 8
Dual-task walking cost will be calculated using walking speed under single-task and dual-task conditions according to the following formula: [(single-task walking speed - dual-task walking speed) / single-task walking speed] × 100%. Walking speed will be measured in meters per second. A higher percentage indicates greater dual-task interference and poorer motor-cognitive performance. The primary analysis will compare the change from baseline to Week 8 among the three study groups.
Baseline and Week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 29, 2026

Primary Completion (Estimated)

October 24, 2026

Study Completion (Estimated)

November 7, 2026

Study Registration Dates

First Submitted

August 28, 2026

First Submitted That Met QC Criteria

August 28, 2026

First Posted (Actual)

September 2, 2026

Study Record Updates

Last Update Posted (Actual)

September 2, 2026

Last Update Submitted That Met QC Criteria

August 28, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AAT-FREQ-RCT-2026-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified individual participant data underlying the results reported in the primary publication will be made available upon reasonable request. Shared data will not include names, contact information, identification numbers, or other direct personal identifiers.

IPD Sharing Time Frame

Data will be available beginning 3 months after publication of the primary study results and will remain available for 5 years.

IPD Sharing Access Criteria

Data may be shared with qualified researchers who submit a methodologically sound research proposal. Requests will be reviewed by the principal investigator and the study institution. Approved researchers will be required to sign a data use agreement and use the data only for the approved purpose. Additional ethics approval will be required when applicable.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe